Jetstream Capital LLC Tg Therapeutics, Inc. Transaction History

Jetstream Capital LLC

  • $1.37 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$21.78 - $40.45 $4.36 Million - $8.09 Million
-200,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$32.5 - $48.96 $2.6 Million - $3.92 Million
80,000 Added 66.67%
200,000 $7.76 Million
Q1 2021

May 17, 2021
BUY
$41.61 - $54.3 $3.66 Million - $4.78 Million
88,000 Added 275.0%
120,000 $5.78 Million
Q4 2020

Feb 16, 2021
BUY
$25.27 - $54.9 $808,640 - $1.76 Million
32,000 New
32,000 $1.67 Million

Others Institutions Holding TGTX

# of Institutions
340
Shares Held
88.5M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.03B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Jetstream Capital LLC Portfolio

Follow Jetstream Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jetstream Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jetstream Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email